| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| HLA-DRB3 |
P79483
|
major histocompatibility complex, class II, DR beta 3
|
Immune response
|
|
0.570 |
0.885 |
| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
| IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
| KIR2DS1 |
Q14954
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1
|
Receptor
|
|
0.537 |
0.769 |
| KIR2DS4 |
P43632
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4
|
Receptor
|
|
0.674 |
0.500 |
| PECAM1 |
P16284
|
platelet and endothelial cell adhesion molecule 1
|
Cell adhesion
|
|
0.426 |
0.846 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| SAI1 |
|
suppression of anchorage independence 1
|
|
|
0.560 |
0.615 |
| TRB |
P0DSE2
|
T cell receptor beta locus
|
|
|
0.636 |
0.538 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| VIS1 |
|
viral integration site 1
|
|
|
0.743 |
0.308 |
| HRX |
|
Hyperreflexia
|
|
|
0.695 |
0.192 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| DLEU2 |
|
deleted in lymphocytic leukemia 2
|
|
|
0.650 |
0.500 |
| UHRF1 |
Q96T88
|
ubiquitin like with PHD and ring finger domains 1
|
|
|
0.540 |
0.692 |
| MIR155HG |
|
MIR155 host gene
|
|
|
0.617 |
0.615 |
| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
| NEAT1 |
|
nuclear paraspeckle assembly transcript 1
|
|
|
0.502 |
0.769 |
| MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
| LINC01194 |
|
long intergenic non-protein coding RNA 1194
|
|
|
0.470 |
0.769 |
| MIR10A |
|
microRNA 10a
|
|
|
0.513 |
0.846 |